Anúncio
Anúncio

CTSO

CTSO logo

Cytosorbents Corp.

0.68
USD
Patrocinado
0.00
+0.59%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

0.68

0.00
0.00%

Relatórios de Lucros CTSO

Rácio de surpresa positiva

CTSO separação 21 de 40 últimas estimativas.

53%

Próximo Relatório

Data do Próximo Relatório
01 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$9.81M
/
-$0.04
Mudanças implicadas de Q4 26 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+7.18%
/
-71.43%

Cytosorbents Corp. earnings per share and revenue

On 02 de jan. de 2026, CTSO reported earnings of -- USD per share (EPS) for Q4 26, -- the estimate of -0.01 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 11.26 milhão, with a --% difference. The market reacted with a +2.60% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of -0.04 USD, with revenue projected to reach 9.81 milhão USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Neogen Corp
Report Date
08 de jan. de 2026 Para Q2 26
Estimativa
$0.05
Real
$0.10
Surpresa
+78.25%
logo
Tilray Brands, Inc. Common Stock
Report Date
08 de jan. de 2026 Para Q2 26
Estimativa
-$0.20
Real
-$0.41
Surpresa
-100.98%
FAQ
For Q4 2026, Cytosorbents Corp. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved up 2.6%, changed from $0.64 before the earnings release to $0.66 the day after.
The next earning report is scheduled for 01 de mar. de 2026.
Based on 5 analistas, Cytosorbents Corp. is expected to report EPS of -$0.04 and revenue of $9.81M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio